Relevant bibliographies by topics / Guideline-Directed Therapy

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Book chapters
  4. Conference papers

Academic literature on the topic 'Guideline-Directed Therapy'

Author: Grafiati
Published: 7 June 2025
Last updated: 2 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Guideline-Directed Therapy.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Guideline-Directed Therapy"

1

Walsh, Mary Norine. "Guideline-Directed Medical Therapy." Journal of the American College of Cardiology 80, no. 16 (2022): 1542–44. http://dx.doi.org/10.1016/j.jacc.2022.08.739.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

O’Connor, Christopher M. "Guideline-Directed Medical Therapy Clinics." JACC: Heart Failure 7, no. 5 (2019): 442–43. http://dx.doi.org/10.1016/j.jchf.2019.04.001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Hess, Connie N., and Marc P. Bonaca. "Guideline-Directed Medical Therapy in PAD." JACC: Cardiovascular Interventions 16, no. 3 (2023): 344–46. http://dx.doi.org/10.1016/j.jcin.2022.10.015.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Sandhu, Alexander T., and Paul A. Heidenreich. "The Affordability of Guideline-Directed Medical Therapy." Circulation 143, no. 11 (2021): 1073–75. http://dx.doi.org/10.1161/circulationaha.120.053291.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Bell, Alan, and Nicholas Giacomantonio. "Guideline-Directed Medical Therapy—Secondary Prevention Checklist." Canadian Journal of Cardiology 40, no. 8 (2024): S53—S56. http://dx.doi.org/10.1016/j.cjca.2024.05.019.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Leyva, Francisco, Carsten W. Israel, and Jagmeet Singh. "Declining Risk of Sudden Cardiac Death in Heart Failure: Fact or Myth?" Circulation 147, no. 9 (2023): 759–67. http://dx.doi.org/10.1161/circulationaha.122.062159.

Full text
Abstract:
The notion that the risk of sudden cardiac death (SCD) in patients with heart failure (HF) is declining seems to be gaining traction. Numerous editorials and commentaries have suggested that SCD, specifically arrhythmic SCD, is no longer a significant risk for patients with HF on guideline-directed medical therapy. In this review, we question whether the risk of SCD has indeed declined in HF trials and in the real world. We also explore whether, despite relative risk reductions, the residual SCD risk after guideline-directed medical therapy still suggests a need for implantable cardioverter de
APA, Harvard, Vancouver, ISO, and other styles
7

Khosravi, Zahra, Muneeb Iqbal, and Sam Kant. "Finerenone: Completing the Cardiorenal Guideline-Directed Medical Therapy?" Kidney News 17, no. 1 (2025): 14. https://doi.org/10.62716/kn.000332024.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Mack, Michael, and Paul Grayburn. "Guideline-Directed Medical Therapy for Secondary Mitral Regurgitation." JACC: Heart Failure 5, no. 9 (2017): 660–62. http://dx.doi.org/10.1016/j.jchf.2017.07.007.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Patolia, Harsh, Muhammad Shahzeb Khan, Gregg C. Fonarow, Javed Butler, and Stephen J. Greene. "Implementing Guideline-Directed Medical Therapy for Heart Failure." Journal of the American College of Cardiology 82, no. 6 (2023): 529–43. http://dx.doi.org/10.1016/j.jacc.2023.03.430.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Crea, Filippo. "Heart failure: how to optimize guideline-directed medical therapy." European Heart Journal 43, no. 27 (2022): 2533–37. http://dx.doi.org/10.1093/eurheartj/ehac356.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Guideline-Directed Therapy"

1

Sisterman, Kathryn, and Kathryn Sisterman. "Improving Care for Patients Hospitalized with Heart Failure." Diss., The University of Arizona, 2017. http://hdl.handle.net/10150/626616.

Full text
Abstract:
Background: Heart failure is a clinical syndrome occurring from the heart’s inability to effectively fill and or pump blood, it is the most common reason for admission in elderly patients. Guideline directed medical therapy refers to implementation of all class I agents to reduce patient morbidity and mortality, unless there is an appropriate contraindication. Appropriate beta blocker (BB), angiotensin converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB), and aldosterone antagonist (AA) are recommended to be prescribed together prior to discharge for a hospital admission fo
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Guideline-Directed Therapy"

1

Fishbein, Daniel. "Acute Decompensated Heart Failure: Treatment with Guideline Directed Medical Therapy and Discharge Planning." In Heart Failure. Springer London, 2017. http://dx.doi.org/10.1007/978-1-4471-4219-5_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Pinho-Gomes, Ana-Catarina, and David P. Taggart. "Guideline-directed medical therapy in coronary artery bypass grafting." In State of the Art Surgical Coronary Revascularization, edited by Marc Ruel and David Glineur. Oxford University Press, 2021. http://dx.doi.org/10.1093/med/9780198758785.003.0082.

Full text
Abstract:
Although mechanical revascularization revolutionized the treatment of coronary artery disease, concomitant guideline-directed medical therapy remains a cornerstone of treatment. Indeed, guideline-directed medical therapy as secondary prevention after coronary revascularization with either percutaneous coronary intervention or coronary artery bypass grafting may be a more important contributor to the risk reduction in mortality achieved by coronary revascularization than the choice between percutaneous or surgical intervention. This chapter explores the importance of GDMT following coronary art
APA, Harvard, Vancouver, ISO, and other styles
3

Asnaani, Anu. "Guideline 6." In A Cultural Humility and Social Justice Approach to Psychotherapy. Oxford University PressNew York, 2023. http://dx.doi.org/10.1093/oso/9780197635971.003.0007.

Full text
Abstract:
Abstract This chapter provides a description, applied example, challenges, and practice tips around the sixth guideline prescribed in A Cultural Humility and Social Justice Approach to Psychotherapy: Seven Applied Guidelines for Evidence-Based Practice. The chapter provides guidance around addressing observed or performed microaggressions directed toward clients, discusses ways to engage in self-work to reduce the likelihood of committing microaggressions in therapy, and presents a worksheet to help address microaggressions that one observes being committed by colleagues or others on treatment
APA, Harvard, Vancouver, ISO, and other styles
4

Rodeheffer, Richard J., Margaret M. Redfield, and Barry A. Boilson. "Pharmacologic and Nonpharmacologic 
Therapy for Systolic Ventricular Dysfunction 
and Heart Failure." In Mayo Clinic Cardiology, 5th ed., edited by Joseph G. Murphy, Nandan S. Anavekar, Barry A. Boilson, Margaret A. Lloyd, Rekha Mankad, and Raymond C. Shields. Oxford University PressNew York, 2024. https://doi.org/10.1093/med/9780197599532.003.0092.

Full text
Abstract:
Abstract All patients with systolic ventricular dysfunction, or heart failure with reduced ejection fraction, should be considered for aggressive treatment of the underlying coronary artery disease, valvular heart disease, or hypertension. The current 2022 American Heart Association/American College of Cardiology/Heart Failure Society of America Guideline for the Management of Heart Failure includes important updates on guideline-directed medical therapy that should be started to reduce morbidity and death, concurrent with the evaluation and management of the underlying cause of ventricular dy
APA, Harvard, Vancouver, ISO, and other styles
5

Omland, Torbjørn. "Trastuzumab-related cardiotoxicity: epidemiology, surveillance, management, prophylaxis, and prognosis." In ESC CardioMed. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198784906.003.0291.

Full text
Abstract:
Trastuzumab is a humanized monoclonal antibody that targets and inhibits the human epidermal growth factor receptor 2 (HER2). Treatment with trastuzumab and other monoclonal antibodies directed at HER2 markedly improves prognosis in patients with HER2-positive breast cancers. Cardiac dysfunction is a frequently occurring and clinically significant side effect of trastuzumab. Trastuzumab-related cardiotoxicity is not dose dependent, not associated with cardiomyocyte necrosis, typically occurs during therapy, and is commonly considered reversible upon interruption of therapy. Recommended surveil
APA, Harvard, Vancouver, ISO, and other styles
6

Aydin, Ani, and Kusum S. Mathews. "Hot and shocky: Distributive/septic shock." In Critical Care Emergencies, edited by Lillian Liang Emlet. Oxford University PressNew York, 2023. http://dx.doi.org/10.1093/med/9780190082581.003.0012.

Full text
Abstract:
Abstract This chapter reviews the most common form of distributive shock, septic shock, and its management. It discusses the significance of early goal-directed therapy (EGDT) in the treatment of sepsis and septic shock, and how the incorporation of portions of this algorithmic approach to septic shock treatment has led to a significant reduction in the mortality associated with this disease over the past 20 years. This chapter also examines current guideline recommendations and approaches to the treatment of septic shock, including fluid resuscitation, vasopressor use, and additional adjuncts
APA, Harvard, Vancouver, ISO, and other styles
7

Martens, Pieter, and Hans-Peter Brunner-La Rocca. "Clinical aspects of chronic kidney disease in heart failure." In The ESC Textbook of Heart Failure, edited by Petar M. Seferović, Andrew J. S. Coats, Gerasimos Filippatos, Stefan D. Anker, Johann Bauersachs, and Giuseppe Rosano. Oxford University PressOxford, 2023. http://dx.doi.org/10.1093/med/9780198891628.003.0066.

Full text
Abstract:
Abstract The kidney and the heart are heavily intertwined and can alter the prognosis of each other. The occurrence of heart failure (HF) in chronic kidney disease (CKD) and vice versa is very common. Adequate evaluation of kidney function encompasses both assessment of glomerular and tubular function, the latter being especially important during decongestive therapy. CKD patients are at higher risk of death from cardiovascular causes and of being admitted for an unplanned heart failure hospitalization. The importance of ensuring adequate lifesaving guideline-directed medical therapy (GDMT) is
APA, Harvard, Vancouver, ISO, and other styles
8

Tomasoni, Daniela, Marianna Adamo, and Marco Metra. "Advanced heart failure: management." In The ESC Textbook of Heart Failure, edited by Petar M. Seferović, Andrew J. S. Coats, Gerasimos Filippatos, Stefan D. Anker, Johann Bauersachs, and Giuseppe Rosano. Oxford University PressOxford, 2023. http://dx.doi.org/10.1093/med/9780198891628.003.0062.

Full text
Abstract:
Abstract Advanced heart failure (HF) represents the stage of HF when conventional therapies are no longer effective in controlling patients’ symptoms and stabilizing the clinical course. In the present chapter, we focus on the importance of optimizing guideline-directed medical therapy, in order to improve prognosis at this advanced stage. Firstly, intolerance to neurohormonal antagonists is often a hallmark of advanced HF and identifies patients with a very poor prognosis, who need non-conventional therapies. Secondly, patients with advanced HF often present volume overload, diuretic resistan
APA, Harvard, Vancouver, ISO, and other styles
9

Böhm, Michael, and Michel Komajda. "Heart rate reduction with ivabradine in heart failure." In The ESC Textbook of Heart Failure, edited by Petar M. Seferović, Andrew J. S. Coats, Gerasimos Filippatos, Stefan D. Anker, Johann Bauersachs, and Giuseppe Rosano. Oxford University PressOxford, 2023. http://dx.doi.org/10.1093/med/9780198891628.003.0045.

Full text
Abstract:
Abstract Ivabradine inhibits hyperpolarization-activated cyclic nucleotide–gated (HCN) channels, and thereby the ‘funny’ channel If, leading to heart rate reduction, which is dependent on the baseline heart rate. Heart failure treatment should be optimized, in addition to guideline-directed and recommended drugs, to achieve an appropriate heart rate (i.e. 50–60 bpm) with use of ivabradine in patients with a heart rate of >70 bpm in sinus rhythm and with an ejection fraction of ≤35% (SHIFT trial). In this trial, heart rate reduction reduced cardiovascular death and heart failure hospital
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Guideline-Directed Therapy"

1

Woods, J., A. Leonhardt, and J. Sebaaly. "Adherence to Guideline-Directed Therapy in the Management of Chronic Obstructive Pulmonary Disease." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3300.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Tent, Michiel. "Application of guideline-directed medical therapy in patients with HFrEF in the Netherlands." In Heart Failure 2024, edited by Marc Bonaca. Medicom Medical Publishers, 2024. http://dx.doi.org/10.55788/9972ee06.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Chattopadhyay, Rahul, Vassilios Vassiliou, Joanna Henderson, et al. "204 The role of the vascular risk modification clinic in achieving guideline-directed lipid lowering therapy: a single-centre observational study." In British Cardiovascular Society Annual Conference, ‘Future-proofing Cardiology for the next 10 years’, 5–7 June 2023. BMJ Publishing Group Ltd and British Cardiovascular Society, 2023. http://dx.doi.org/10.1136/heartjnl-2023-bcs.204.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Chiong, Justin, and Athar Badar. "160 An audit of guideline directed medical therapy initiation for patients admitted to hospital for an acute decompensation of heart failure." In British Cardiovascular Society Annual Conference, ‘Future-proofing Cardiology for the next 10 years’, 5–7 June 2023. BMJ Publishing Group Ltd and British Cardiovascular Society, 2023. http://dx.doi.org/10.1136/heartjnl-2023-bcs.160.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Lehane, M., O. McGoey, N. Caples, et al. "4 Titration of heart failure guideline directed therapy: a comparison between the performance of Irish heart failure nurses and observational registries." In Irish Cardiac Society 74th Annual Scientific Meeting & AGM, October 12th–14th 2023, Killashee House Hotel, Kildare, Ireland. BMJ Publishing Group Ltd and British Cardiovascular Society, 2023. http://dx.doi.org/10.1136/heartjnl-2023-ics.4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Hampal, Rumneek, Firas Hamdan, Timothy Bagnall, et al. "226 Are patients with stable angina established on guideline directed optimal medical therapy prior to elective percutaneous coronary intervention? A single centre experience." In British Cardiovascular Society Annual Conference, ‘Back to the patient’, 3–5 June 2024. BMJ Publishing Group Ltd and British Cardiovascular Society, 2024. http://dx.doi.org/10.1136/heartjnl-2024-bcs.218.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Krishnan, Sunanthiny, Shirley Sze, and Iain Squire. "170 An evidence-based approach to overcoming barriers in initiating and up-titrating guideline- directed medical therapy in patients with heart failure with reduced ejection fraction." In British Cardiovascular Society Annual Conference, ‘Back to the patient’, 3–5 June 2024. BMJ Publishing Group Ltd and British Cardiovascular Society, 2024. http://dx.doi.org/10.1136/heartjnl-2024-bcs.167.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Galvin, O., G. O’Dea, and G. Murphy. "3 DOES the use of resource efficient checklists improve guideline directed medical therapy prescription rates and outcomes for patients admitted with decompensated heart failure – a systematic review." In Irish Cardiac Society 74th Annual Scientific Meeting & AGM, October 12th–14th 2023, Killashee House Hotel, Kildare, Ireland. BMJ Publishing Group Ltd and British Cardiovascular Society, 2023. http://dx.doi.org/10.1136/heartjnl-2023-ics.3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Soh, BWT, R. Cusack, K. O’Brien, et al. "58 Strategies to optimise guideline-directed medical therapy in heart failure patients with reduced ejection fraction by improving SGLT2i initiation rates in nurse-led outpatient heart failure clinics." In Irish Cardiac Society Annual Scientific Meeting & AGM, October 6th – 8th 2022, Radisson Hotel, Little Island, Cork Ireland. BMJ Publishing Group Ltd and British Cardiovascular Society, 2022. http://dx.doi.org/10.1136/heartjnl-2022-ics.58.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Nazir, Anum, Lokesh Sivanandam, Aleksandra Idzik, and Lampson Fan. "79 Improving guideline directed dual anti-platelet therapy administration and appropriate timing of second antiplatelet loading in patients presenting with non-ST elevation myocardial infarction (NSTEMI) and unstable angina." In British Cardiovascular Society Annual Conference, ‘Back to the patient’, 3–5 June 2024. BMJ Publishing Group Ltd and British Cardiovascular Society, 2024. http://dx.doi.org/10.1136/heartjnl-2024-bcs.79.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Guideline-Directed Therapy' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography